Ferdinandos Skoulidis, Hossein Borghaei, Edward B. Garon, Ticiana Leal, Jacob Kaufman, Stephen V. Liu, Eric S. Nadler, Sandip Pravin Patel, Solange Peters, Biagio Ricciuti, Tarek Mekhail, Ajeet Gajra, Eric C. McGary, Vu Phan, James Stevenson, Richard Lynen, Ugochinyere Emeribe, Aida Myftiu, Ashish Gautam, John V. Heymach. "Tremelimumab (T) + durvalumab (D) + chemotherapy (CT) vs pembrolizumab (P) + CT in 1L non-squamous (NSQ) metastatic NSCLC (mNSCLC) with STK11 , KEAP1 , and/or KRAS mutations (mut): Interim analysis (IA) of the phase 2b TRITON study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8515